Answers are grounded in this paper and cite their sources.
Clinical review links depression to increased mortality and graft loss in organ transplant recipients, suggesting screening and treatment may improve outcomes.
Depression increases risk for posttransplant mortality. Few studies considered morbidities; the depression-graft loss association suggests that linkages with morbidities deserve greater attention. Depression screening and treatment may be warranted, although whether these activities would reduce posttransplant mortality requires study.
No takes yet. Share an insight, caveat, or question.
Dew et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: